RXRX: Recursion Pharmaceuticals Inc - Class A
今日RXRX汇率已更改-3.79%。当日,交易品种以低点3.55和高点3.74进行交易。
关注Recursion Pharmaceuticals Inc - Class A动态。实时报价将帮助您快速应对市场变化。通过在不同的时间周期之间切换,您可以按分钟、小时、天、周和月监控汇率趋势和动态。使用这些信息来预测市场变化并做出明智的交易决策。
- M5
- M15
- M30
- H1
- H4
- D1
- W1
- MN
RXRX新闻
- Recursion Pharmaceuticals, Inc. (RXRX) Presents at 25th Annual Needham Virtual Healthcare Conference Transcript
- Recursion Pharmaceuticals (RXRX) Stock Drops Despite Market Gains: Important Facts to Note
- Recursion Pharmaceuticals (RXRX) Stock Declines While Market Improves: Some Information for Investors
- Recursion Pharmaceuticals (RXRX) Beats Stock Market Upswing: What Investors Need to Know
- Here's Why Recursion Pharmaceuticals (RXRX) Fell More Than Broader Market
- Recursion Pharmaceuticals (RXRX) Down 16.5% Since Last Earnings Report: Can It Rebound?
- Bitcoin Skids, $14 Bil In Options Due; Cathie Wood Raises Cash
- Recursion Pharmaceuticals, Inc. (RXRX) Presents at 2026 KeyBanc Capital Markets Healthcare Virtual Forum Transcript
- Recursion Pharmaceuticals (RXRX) Advances While Market Declines: Some Information for Investors
- Rose the dog might have just heralded the age of programmable medicine — and here are the stocks that benefit
- Recursion Pharmaceuticals (RXRX) Sees a More Significant Dip Than Broader Market: Some Facts to Know
- PacBio任命Recursion联合创始人Gibson加入董事会
- Pacira BioSciences Q4 Earnings and Revenues Miss Estimates, Stock Down
- Xenon Q4 Loss Wider Than Expected, Pipeline Development in Focus
- Catalyst Pharmaceuticals Q4 Earnings Beat, Firdapse Revenues Rise Y/Y
- ACAD Q4 Earnings Beat, Nuplazid & Daybue Drive Y/Y Revenue Growth
- Recursion Pharmaceuticals, Inc. 2025 Q4 - Results - Earnings Call Presentation (NASDAQ:RXRX) 2026-02-25
- Recursion Pharmaceuticals Q4: Why My December Buy Call Was Too Optimistic (NASDAQ:RXRX)
- 美银下调Recursion Pharmaceuticals目标价,因产品上市时间调整
- BofA cuts Recursion Pharmaceuticals stock price target on launch timing
- Recursion Pharmaceuticals (RXRX) Reports Q4 Loss, Beats Revenue Estimates
- RXRX Q4 Loss Narrower Than Expected, Revenues Increase Y/Y, Stock Up
- Recursion 2025年第四季度业绩:AI平台首次获得临床概念验证
- Recursion Q4 2025 slides: AI platform delivers first clinical proof-of-concept
常见问题解答
RXRX股票今天的价格是多少?
Recursion Pharmaceuticals Inc - Class A股票今天的定价为3.55。它在3.55 - 3.74范围内交易,昨天的收盘价为3.69,交易量达到9853。RXRX的实时价格图表显示了这些更新。
Recursion Pharmaceuticals Inc - Class A股票是否支付股息?
Recursion Pharmaceuticals Inc - Class A目前的价值为3.55。股息政策取决于公司,而投资者也会关注-37.28%和USD。实时查看图表以跟踪RXRX走势。
如何购买RXRX股票?
您可以以3.55的当前价格购买Recursion Pharmaceuticals Inc - Class A股票。订单通常设置在3.55或3.85附近,而9853和-4.05%显示市场活动。立即关注RXRX的实时图表更新。
如何投资RXRX股票?
投资Recursion Pharmaceuticals Inc - Class A需要考虑年度范围2.80 - 7.18和当前价格3.55。许多人在以3.55或3.85下订单之前,会比较13.42%和。实时查看RXRX价格图表,了解每日变化。
Recursion Pharmaceuticals Inc - Class A股票的最高价格是多少?
在过去一年中,Recursion Pharmaceuticals Inc - Class A的最高价格是7.18。在2.80 - 7.18内,该股波动显著,与相比有助于发现阻力位。使用实时图表跟踪Recursion Pharmaceuticals Inc - Class A的绩效。
Recursion Pharmaceuticals Inc - Class A股票的最低价格是多少?
Recursion Pharmaceuticals Inc - Class A(RXRX)的最低价格为2.80。将其与当前的3.55和2.80 - 7.18进行比较,可以发现潜在的长期切入点。观看RXRX在图表上的实时走势以获取更多详细信息。
RXRX股票是什么时候拆分的?
Recursion Pharmaceuticals Inc - Class A历史上曾经历过股票拆分。这些变化在公司行动后的、3.69和-37.28%中可见。
- 前一天收盘价
- 3.69
- 开盘价
- 3.70
- 卖价
- 3.55
- 买价
- 3.85
- 最低价
- 3.55
- 最高价
- 3.74
- 交易量
- 9.853 K
- 日变化
- -3.79%
- 月变化
- 13.42%
- 6个月变化
- -36.04%
- 年变化
- -37.28%
- 实际值
- 预测值
- 0.705 M
- 前值
- -0.913 M
- 实际值
- 预测值
- 0.076 M
- 前值
- -1.727 M
- 实际值
- 预测值
- 前值
- 4.817%